Innovation and R&D
Advanced Medical Solutions is committed to providing innovative solutions that enhance the safety, efficiency and effectiveness of surgical procedures and advanced wound care for healthcare professionals and patients alike.
Our product development pipeline is driven by R&D Innovation Hubs in the UK, Germany, France, Israel, and Ireland. Our globally recognised brands are focused on pioneering tissue-healing technologies with increasing investments in research and development fuelling our commitment to improving the patient experience.
Our expanding portfolio of innovative tissue-healing products has been established through increased investment in our specialist R&D hubs and strategic acquisitions. In diversifying our portfolio, we have reduced our reliance on any single market and ensured a more consistent group performance.
We achieve our innovation goals by taking proactive steps, including:
- Developing and engaging with clinical advisory boards.
- Expanding our relationships with key opinion leader panels to provide expert input into the innovation process and to ensure our products meet clinical needs.
- Working in collaboration with our customers to understand their needs earlier in the process and influence our development focus.
- Utilising centres of excellence for innovation and ensuring resources and ideas are shared across the group.
- Creating differentiated products that provide more effective experiences for both clinicians and patients.
- Exploiting technology for continuous improvement and iterative innovation.
- Investing in our people and processes in line with increasing global regulatory and clinical requirements.